(2S)-2-(1-Oxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid

Catalog No. :
ACPNHF763
CAS No. :
105776-76-9
Molecular Formula :
C17H15NO3
Molecular Weight :
281.31

IUPAC Name:(S)-2-(1-oxoisoindolin-2-yl)-3-phenylpropanoic acid

(2S)-2-(1-Oxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
250mg95%$254.00Login to see priceInquiryInquiry
1g95%$605.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2S)-2-(1-Oxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid
IUPAC Name(S)-2-(1-oxoisoindolin-2-yl)-3-phenylpropanoic acid
MDL No.MFCD11868494
Molecular FormulaC17H15NO3
Molecular Weight281.31
SMILESO=C(O)[C@@H](N(CC1=C2C=CC=C1)C2=O)CC3=CC=CC=C3
InChI KeyFZEBPJBRDFXKIH-HNNXBMFYSA-N
Synonym(2S)-2-(1-oxo-2,3-dihydro-1H-isoindol-2-yl)-3-phenylpropanoic acid;(S)-2-(1-oxoisoindolin-2-yl)-3-phenylpropanoic acid;2H-Isoindole-2-acetic acid, 1,3-dihydro-1-oxo-α-(phenylmethyl)-, (αS)-;(2S)-2-(3-oxo-1H-isoindol-2-yl)-3-phenylpropanoic acid;2H-Isoindole-2-acetic acid, 1,3-dihydro-1-oxo-a-(phenylmethyl)-, (S)-
CAS No.105776-76-9

Safety Data

Pictogram
Harmful or irritant
Signal Word
Achtung
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P264-P270-P271-P280-P301+P312-P302+P352-P304+P340-P305+P351+P338-P330-P332+P313-P337+P313-P362-P403+P233-P405-P501

Synthetic Route by SureRoute

1. ACPNHF763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPNHF763 route product structure diagram
    ACPNHF763105776-76-9
Inquiry

2. ACPNHF763 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACPNHF763 route product structure diagram
    ACPNHF763105776-76-9
Inquiry

Comments (0)